BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ingle L, Shelton RJ, Rigby AS, Nabb S, Clark AL, Cleland JG. The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure. Eur Heart J 2005;26:1742-51. [PMID: 15831556 DOI: 10.1093/eurheartj/ehi259] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Frankenstein L, Zugck C, Nelles M, Schellberg D, Katus H, Remppis A. Sex-specific Predictive Power of 6-Minute Walk Test in Chronic Heart Failure Is Not Enhanced Using Percent Achieved of Published Reference Equations. The Journal of Heart and Lung Transplantation 2008;27:427-34. [DOI: 10.1016/j.healun.2008.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
2 Farquhar JM, Smith PJ, Snyder L, Gray AL, Reynolds JM, Blumenthal JA. Patterns and predictors of pain following lung transplantation. General Hospital Psychiatry 2018;50:125-30. [DOI: 10.1016/j.genhosppsych.2017.11.007] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
3 Beatty AL, Schiller NB, Whooley MA. Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med 2012;172:1096-102. [PMID: 22710902 DOI: 10.1001/archinternmed.2012.2198] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 8.3] [Reference Citation Analysis]
4 Clark AL, Johnson M, Fairhurst C, Torgerson D, Cockayne S, Rodgers S, Griffin S, Allgar V, Jones L, Nabb S, Harvey I, Squire I, Murphy J, Greenstone M. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure. Health Technol Assess 2015;19:1-120. [PMID: 26393373 DOI: 10.3310/hta19750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
5 Hassan AK, Dimitry SR, Agban GW. Can exercise capacity assessed by the 6 minute walk test predict the development of major adverse cardiac events in patients with STEMI after fibrinolysis? PLoS One 2014;9:e99035. [PMID: 24905094 DOI: 10.1371/journal.pone.0099035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 O'neill HS, Gallagher LB, O'sullivan J, Whyte W, Curley C, Dolan E, Hameed A, O'dwyer J, Payne C, O'reilly D, Ruiz-hernandez E, Roche ET, O'brien FJ, Cryan SA, Kelly H, Murphy B, Duffy GP. Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives. Adv Mater 2016;28:5648-61. [DOI: 10.1002/adma.201505349] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
7 Raissuni Z, Roul G. Comparison of the long-term reproducibility of the walk test and of exercise peak oxygen consumption in patients with preserved exercise capacity. Acta Cardiol 2018;73:155-62. [PMID: 28745141 DOI: 10.1080/00015385.2017.1351250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Gardiner FW, Regan E, Nwose EU, Bwititi PT, Crockett J, Wang L. Outpatient cardiac rehabilitation: Effects on patient improvement outcomes. Diabetes Metab Syndr 2017;11 Suppl 2:S1025-30. [PMID: 28781162 DOI: 10.1016/j.dsx.2017.07.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Baldasseroni S, Mossello E, Romboli B, Orso F, Colombi C, Fumagalli S, Ungar A, Tarantini F, Masotti G, Marchionni N. Relationship between cognitive function and 6-minute walking test in older outpatients with chronic heart failure. Aging Clin Exp Res 2010;22:308-13. [PMID: 21116123 DOI: 10.1007/BF03324936] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
10 Johansen KL, Finkelstein FO, Revicki DA, Gitlin M, Evans C, Mayne TJ. Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated With Erythropoiesis-Stimulating Agents. American Journal of Kidney Diseases 2010;55:535-48. [DOI: 10.1053/j.ajkd.2009.12.018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
11 Valborgland T, Isaksen K, Munk PS, Larsen AI. Blood Lactate AUC Is a Sensitive Test for Evaluating the Effect of Exercise Training on Functional Work Capacity in Patients with Chronic Heart Failure. Rehabil Res Pract 2021;2021:6619747. [PMID: 34631167 DOI: 10.1155/2021/6619747] [Reference Citation Analysis]
12 Katz E, Dugan NL, Cohn JC, Chu C, Smith RG, Schmitz KH. Weight lifting in patients with lower-extremity lymphedema secondary to cancer: a pilot and feasibility study. Arch Phys Med Rehabil 2010;91:1070-6. [PMID: 20599045 DOI: 10.1016/j.apmr.2010.03.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
13 Wachter R, Shah SJ, Cowie MR, Szecsödy P, Shi V, Ibram G, Zhao Z, Gong J, Klebs S, Pieske B. Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial. ESC Heart Fail 2020;7:856-64. [PMID: 32297449 DOI: 10.1002/ehf2.12694] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
14 Travensolo C, Goessler K, Poton R, Pinto RR, Polito MD. Medida do desempenho físico por testes de campo em programas de reabilitação cardiovascular: revisão sistemática e meta‐análise. Revista Portuguesa de Cardiologia 2018;37:525-37. [DOI: 10.1016/j.repc.2017.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Pieske B, Wachter R, Shah SJ, Baldridge A, Szeczoedy P, Ibram G, Shi V, Zhao Z, Cowie MR; PARALLAX Investigators and Committee members. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial. JAMA 2021;326:1919-29. [PMID: 34783839 DOI: 10.1001/jama.2021.18463] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Seo Y, Yates BC, Norman JF, Pozehl B, Kupzyk K. Comparisons of Dyspnea, Fatigue, and Exercise Intolerance Between Individuals with Heart Failure with High Versus Low Knee Extensor Muscle Strength: . Cardiopulmonary Physical Therapy Journal 2014;25:11-7. [DOI: 10.1097/01823246-201403000-00004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Du H, Wonggom P, Tongpeth J, Clark RA. Six-Minute Walk Test for Assessing Physical Functional Capacity in Chronic Heart Failure. Curr Heart Fail Rep 2017;14:158-66. [PMID: 28421409 DOI: 10.1007/s11897-017-0330-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
18 Foley PW, Leyva F, Frenneaux MP. What is treatment success in cardiac resynchronization therapy? Europace 2009;11 Suppl 5:v58-65. [PMID: 19861392 DOI: 10.1093/europace/eup308] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
19 Patarroyo-Aponte M, Colvin-Adams M. Evaluation of patients with heart failure. Cardiol Clin 2014;32:47-62, viii. [PMID: 24286578 DOI: 10.1016/j.ccl.2013.09.014] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
20 Mann DL, Lee RJ, Coats AJ, Neagoe G, Dragomir D, Pusineri E, Piredda M, Bettari L, Kirwan B, Dowling R, Volterrani M, Solomon SD, Sabbah HN, Hinson A, Anker SD. One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure: One-year follow-up results from AUGMENT-HF. Eur J Heart Fail 2016;18:314-25. [DOI: 10.1002/ejhf.449] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
21 Ng SS, Tsang WW, Cheung TH, Chung JS, To FP, Yu PC. Walkway length, but not turning direction, determines the six-minute walk test distance in individuals with stroke. Arch Phys Med Rehabil 2011;92:806-11. [PMID: 21530729 DOI: 10.1016/j.apmr.2010.10.033] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
22 Clark AL. Origin of symptoms in chronic heart failure. Heart 2006;92:12-6. [PMID: 16159969 DOI: 10.1136/hrt.2005.066886] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 5.2] [Reference Citation Analysis]
23 Lepore JJ, Olson E, Demopoulos L, Haws T, Fang Z, Barbour AM, Fossler M, Davila-Roman VG, Russell SD, Gropler RJ. Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction. JACC Heart Fail. 2016;4:559-566. [PMID: 27039125 DOI: 10.1016/j.jchf.2016.01.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
24 Szczegielniak J, Latawiec KJ, Łuniewski J, Stanisławski R, Bogacz K, Krajczy M, Rydel M. A study on nonlinear estimation of submaximal effort tolerance based on the generalized MET concept and the 6MWT in pulmonary rehabilitation. PLoS One 2018;13:e0191875. [PMID: 29425213 DOI: 10.1371/journal.pone.0191875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
25 Ingle L, Cleland JG, Clark AL. The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. Biomed Res Int 2014;2014:505969. [PMID: 24800236 DOI: 10.1155/2014/505969] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
26 Ingle L, Carroll S. THE 6-MIN WALK TEST: A USEFUL TEST IN ELDERLY PATIENTS WITH HEART FAILURE? Medicine & Science in Sports & Exercise 2007;39:391. [DOI: 10.1249/01.mss.0000246995.56352.a5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
27 Shoemaker MJ, Curtis AB, Vangsnes E, Dickinson MG. Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure. Cardiopulm Phys Ther J. 2013;24:21-29. [PMID: 23997688 DOI: 10.1097/01823246-201324030-00004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 38] [Article Influence: 7.9] [Reference Citation Analysis]
28 Frankenstein L, Remppis A, Graham J, Schellberg D, Sigg C, Nelles M, Katus H, Zugck C. Gender and age related predictive value of walk test in heart failure: Do anthropometrics matter in clinical practice? International Journal of Cardiology 2008;127:331-6. [DOI: 10.1016/j.ijcard.2007.04.087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
29 Saka K, Konishi M, Kagiyama N, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, Misumi T, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Makino A, Oka K, Kimura K, Tamura K, Momomura SI, Matsue Y. Impact of physical performance on exercise capacity in older patients with heart failure with reduced and preserved ejection fraction. Exp Gerontol 2021;156:111626. [PMID: 34780931 DOI: 10.1016/j.exger.2021.111626] [Reference Citation Analysis]
30 Johnson MJ, Cockayne S, Currow DC, Bell K, Hicks K, Fairhurst C, Gabe R, Torgerson D, Jefferson L, Oxberry S, Ghosh J, Hogg KJ, Murphy J, Allgar V, Cleland JGF, Clark AL. Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial. ESC Heart Fail 2019;6:1149-60. [PMID: 31389157 DOI: 10.1002/ehf2.12498] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
31 Beltrán P, Palau P, Domínguez E, Faraudo M, Núñez E, Guri O, Mollar A, Sanchis J, Bayés-Genís A, Núñez J. Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study. Int J Cardiol 2018;252:136-9. [PMID: 29249422 DOI: 10.1016/j.ijcard.2017.10.074] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
32 Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail. 2009;15:171-181. [PMID: 19327618 DOI: 10.1016/j.cardfail.2009.01.013] [Cited by in Crossref: 311] [Cited by in F6Publishing: 283] [Article Influence: 23.9] [Reference Citation Analysis]
33 Klompstra L, Jaarsma T, Strömberg A. Exergaming to increase the exercise capacity and daily physical activity in heart failure patients: a pilot study. BMC Geriatr 2014;14:119. [PMID: 25407612 DOI: 10.1186/1471-2318-14-119] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
34 Yamada K, Kinugasa Y, Sota T, Miyagi M, Sugihara S, Kato M, Yamamoto K. Inspiratory Muscle Weakness is Associated With Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction: A Preliminary Study. J Card Fail 2016;22:38-47. [PMID: 26505812 DOI: 10.1016/j.cardfail.2015.10.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
35 Frankenstein L, Goode K, Ingle L, Remppis A, Schellberg D, Nelles M, Katus H, Clark A, Cleland J, Zugck C. Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status – Do we need specificity for sex and beta-blockers? International Journal of Cardiology 2011;147:74-8. [DOI: 10.1016/j.ijcard.2009.08.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
36 Palau P, Domínguez E, López L, Heredia R, González J, Ramón JM, Serra P, Santas E, Bodi V, Sanchis J, Chorro FJ, Núñez J. Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial. Clin Cardiol 2016;39:433-9. [PMID: 27481035 DOI: 10.1002/clc.22555] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Hu Y, Jiang S, Lu S, Xu R, Huang Y, Zhao Z, Qu Y. Echocardiography and Electrocardiography Variables Correlate With the New York Heart Association classification: An Observational Study of Ischemic Cardiomyopathy Patients. Medicine (Baltimore) 2017;96:e7071. [PMID: 28658100 DOI: 10.1097/MD.0000000000007071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
38 Kersten J, Baumhardt M, Hartveg P, Hoyo L, Hüll E, Imhof A, Kropf-Sanchen C, Nita N, Mörike J, Rattka M, Andreß S, Scharnbeck D, Schmidtke-Schrezenmeier G, Tadic M, Wolf A, Rottbauer W, Buckert D. Long COVID: Distinction between Organ Damage and Deconditioning. J Clin Med 2021;10:3782. [PMID: 34501230 DOI: 10.3390/jcm10173782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Willey JZ, Moon YP, Kulick ER, Cheung YK, Wright CB, Sacco RL, Elkind MSV. Physical Inactivity Predicts Slow Gait Speed in an Elderly Multi-Ethnic Cohort Study: The Northern Manhattan Study. Neuroepidemiology 2017;49:24-30. [PMID: 28810247 DOI: 10.1159/000479695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
40 Jaarsma T, Klompstra L, Ben Gal T, Ben Avraham B, Boyne J, Bäck M, Chialà O, Dickstein K, Evangelista L, Hagenow A, Hoes AW, Hägglund E, Piepoli MF, Vellone E, Zuithoff NPA, Mårtensson J, Strömberg A. Effects of exergaming on exercise capacity in patients with heart failure: results of an international multicentre randomized controlled trial. Eur J Heart Fail 2021;23:114-24. [PMID: 32167657 DOI: 10.1002/ejhf.1754] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
41 Gasparini M, Regoli F, Ceriotti C, Galimberti P, Bragato R, De Vita S, Pini D, Andreuzzi B, Mangiavacchi M, Klersy C. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: Temporal pattern and clinical predictors. American Heart Journal 2008;155:507-14. [DOI: 10.1016/j.ahj.2007.10.028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
42 Witte KK, Clark AL. Why does chronic heart failure cause breathlessness and fatigue? Prog Cardiovasc Dis 2007;49:366-84. [PMID: 17329182 DOI: 10.1016/j.pcad.2006.10.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
43 Ingle L. Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Fail Rev 2007;12:12-22. [DOI: 10.1007/s10741-007-9000-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
44 Jaarsma T, Perkiö Kato N, Ben Gal T, Bäck M, Chialà O, Evangelista L, Mårtensson J, Piepoli MF, Vellone E, Klompstra L, Strömberg A; HF-Wii study team. Factors associated with lack of improvement in submaximal exercise capacity of patients with heart failure. ESC Heart Fail 2021. [PMID: 34480412 DOI: 10.1002/ehf2.13584] [Reference Citation Analysis]
45 Giordano A, Scalvini S, Paganoni AM, Baraldo S, Frigerio M, Vittori C, Borghi G, Marzegalli M, Agostoni O. Home-Based Telesurveillance Program in Chronic Heart Failure: Effects on Clinical Status and Implications for 1-Year Prognosis. Telemedicine and e-Health 2013;19:605-12. [DOI: 10.1089/tmj.2012.0250] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
46 Ferreira JP, Metra M, Anker SD, Dickstein K, Lang CC, Ng L, Samani NJ, Cleland JG, van Veldhuisen DJ, Voors AA, Zannad F. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. Eur J Heart Fail 2019;21:218-26. [PMID: 30600578 DOI: 10.1002/ejhf.1380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
47 Ingle L. A Review of the Six-Minute Walk Test: Its Implication as a Self-Administered Assessment Tool. European Journal of Cardiovascular Nursing 2009;8:232-4. [DOI: 10.1016/j.ejcnurse.2009.01.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
48 Zachariah D, Taylor J, Rowell N, Spooner C, Kalra PR. Drug therapy for heart failure in older patients-what do they want? J Geriatr Cardiol 2015;12:165-73. [PMID: 25870620 DOI: 10.11909/j.issn.1671-5411.2015.02.011] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
49 Koshy AO, Gallivan ER, McGinlay M, Straw S, Drozd M, Toms AG, Gierula J, Cubbon RM, Kearney MT, Witte KK. Prioritizing symptom management in the treatment of chronic heart failure. ESC Heart Fail 2020;7:2193-207. [PMID: 32757363 DOI: 10.1002/ehf2.12875] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
50 Ingle L. Prognostic value and diagnostic potential of cardiopulmonary exercise testing in patients with chronic heart failure. European Journal of Heart Failure 2008;10:112-8. [DOI: 10.1016/j.ejheart.2007.12.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
51 Anker SD, Coats AJ, Cristian G, Dragomir D, Pusineri E, Piredda M, Bettari L, Dowling R, Volterrani M, Kirwan BA, Filippatos G, Mas JL, Danchin N, Solomon SD, Lee RJ, Ahmann F, Hinson A, Sabbah HN, Mann DL. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial). Eur Heart J 2015;36:2297-309. [PMID: 26082085 DOI: 10.1093/eurheartj/ehv259] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 12.6] [Reference Citation Analysis]
52 Vona M, Mazzuero G, Lupi A, Vettorato C, Bosso P, Cohen-solal A. Effects of altitude on effort tolerance in non-acclimatized patients with ischemic left ventricular dysfunction. European Journal of Cardiovascular Prevention & Rehabilitation 2016;13:617-24. [DOI: 10.1097/01.hjr.0000220583.27140.9b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
53 Pepera GK, Sandercock GR, Sloan R, Cleland JJ, Ingle L, Clark AL. Influence of step length on 6-minute walk test performance in patients with chronic heart failure. Physiotherapy 2012;98:325-9. [PMID: 23122439 DOI: 10.1016/j.physio.2011.08.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
54 Nilsson BB, Westheim A, Risberg MA. Effects of group-based high-intensity aerobic interval training in patients with chronic heart failure. Am J Cardiol 2008;102:1361-5. [PMID: 18993156 DOI: 10.1016/j.amjcard.2008.07.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
55 Vuckovic KM, Fink AM. The 6-min walk test: is it an effective method for evaluating heart failure therapies? Biol Res Nurs 2012;14:147-59. [PMID: 21586495 DOI: 10.1177/1099800411403918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Hauptman PJ, Rich MW, Heidenreich PA, Chin J, Cummings N, Dunlap ME, Edwards ML, Gregory D, O'connor CM, Pezzella SM, Philbin E. The Heart Failure Clinic: A Consensus Statement of the Heart Failure Society of America. Journal of Cardiac Failure 2008;14:801-15. [DOI: 10.1016/j.cardfail.2008.10.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
57 Toblli JE, Lombraña A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-65. [PMID: 17950147 DOI: 10.1016/j.jacc.2007.07.029] [Cited by in Crossref: 241] [Cited by in F6Publishing: 210] [Article Influence: 16.1] [Reference Citation Analysis]
58 Eddicks S, Maier-Hauff K, Schenk M, Müller A, Baumann G, Theres H. Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study. Heart 2007;93:585-90. [PMID: 17237126 DOI: 10.1136/hrt.2006.100784] [Cited by in Crossref: 105] [Cited by in F6Publishing: 81] [Article Influence: 7.0] [Reference Citation Analysis]
59 Ingle L, Rigby A, Nabb S, Jones P, Clark A, Cleland J. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. European Journal of Heart Failure 2006;8:321-5. [DOI: 10.1016/j.ejheart.2005.08.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
60 Täger T, Hanholz W, Cebola R, Fröhlich H, Franke J, Doesch A, Katus HA, Wians FH, Frankenstein L. Minimal important difference for 6-minute walk test distances among patients with chronic heart failure. International Journal of Cardiology 2014;176:94-8. [DOI: 10.1016/j.ijcard.2014.06.035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
61 Baldasseroni S, Pratesi A, Orso F, Foschini A, Marella AG, Bartoli N, Mossello E, Bari MD, Marchionni N, Tarantini F. Age-related impact of depressive symptoms on functional capacity measured with 6-minute walking test in coronary artery disease. Eur J Prev Cardiol 2014;21:647-54. [PMID: 23787796 DOI: 10.1177/2047487313494581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Bunsawat K, Ratchford SM, Alpenglow JK, Park SH, Jarrett CL, Stehlik J, Smith AS, Richardson RS, Wray DW. Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction. J Appl Physiol (1985) 2021;130:256-68. [PMID: 33211601 DOI: 10.1152/japplphysiol.00454.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Tollár J, Nagy F, Moizs M, Tóth BE, Sanders LMJ, Hortobágyi T. Diverse Exercises Similarly Reduce Older Adults’ Mobility Limitations. Medicine & Science in Sports & Exercise 2019;51:1809-16. [DOI: 10.1249/mss.0000000000002001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Reibis RK, Treszl A, Wegscheider K, Ehrlich B, Dissmann R, Völler H. Exercise Capacity Is the Most Powerful Predictor of 2-Year Mortality in Patients with Left Ventricular Systolic Dysfunction. Herz 2010;35:104-10. [DOI: 10.1007/s00059-010-3226-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
65 Brooks GC, Vittinghoff E, Iyer S, Tandon D, Kuhar P, Madsen KA, Marcus GM, Pletcher MJ, Olgin JE. Accuracy and Usability of a Self-Administered 6-Minute Walk Test Smartphone Application. Circ Heart Fail 2015;8:905-13. [PMID: 26283292 DOI: 10.1161/CIRCHEARTFAILURE.115.002062] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
66 Johnson MJ, Booth S, Currow DC, Lam LT, Phillips JL. A Mixed-Methods, Randomized, Controlled Feasibility Trial to Inform the Design of a Phase III Trial to Test the Effect of the Handheld Fan on Physical Activity and Carer Anxiety in Patients With Refractory Breathlessness. J Pain Symptom Manage 2016;51:807-15. [PMID: 26880253 DOI: 10.1016/j.jpainsymman.2015.11.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
67 Chiarantini D, Volpato S, Sioulis F, Bartalucci F, Del Bianco L, Mangani I, Pepe G, Tarantini F, Berni A, Marchionni N, Di Bari M. Lower extremity performance measures predict long-term prognosis in older patients hospitalized for heart failure. J Card Fail. 2010;16:390-395. [PMID: 20447574 DOI: 10.1016/j.cardfail.2010.01.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 7.3] [Reference Citation Analysis]
68 Ingle L, Cleland J, Clark A. The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure. Annals of Physical and Rehabilitation Medicine 2014;57:244-53. [DOI: 10.1016/j.rehab.2014.03.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
69 Comín-Colet J, Garin O, Lupón J, Manito N, Crespo-Leiro MG, Gómez-Bueno M, Ferrer M, Artigas R, Zapata A, Elosua R; VALIC-KC study group. Validation of the Spanish version of the Kansas city cardiomyopathy questionnaire. Rev Esp Cardiol 2011;64:51-8. [PMID: 21194819 DOI: 10.1016/j.recesp.2010.10.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
70 Ingle L, Reddy P, Clark AL, Cleland JG. Diabetes Lowers Six-Minute Walk Test Performance in Heart Failure. Journal of the American College of Cardiology 2006;47:1909-10. [DOI: 10.1016/j.jacc.2006.02.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
71 Miyagi M, Kinugasa Y, Sota T, Yamada K, Ishisugi T, Hirai M, Yanagihara K, Haruki N, Matsubara K, Kato M, Yamamoto K. Diaphragm Muscle Dysfunction in Patients With Heart Failure. Journal of Cardiac Failure 2018;24:209-16. [DOI: 10.1016/j.cardfail.2017.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
72 Jaarsma T, Klompstra L, Ben Gal T, Boyne J, Vellone E, Bäck M, Dickstein K, Fridlund B, Hoes A, Piepoli MF, Chialà O, Mårtensson J, Strömberg A. Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF-Wii study; a multicentre randomized controlled trial. Eur J Heart Fail 2015;17:743-8. [PMID: 26139585 DOI: 10.1002/ejhf.305] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
73 Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation. 2011;124:304-313. [PMID: 21709064 DOI: 10.1161/circulationaha.111.022889] [Cited by in Crossref: 529] [Cited by in F6Publishing: 293] [Article Influence: 48.1] [Reference Citation Analysis]
74 Pihl E, Cider A, Strömberg A, Fridlund B, Mårtensson J. Exercise in elderly patients with chronic heart failure in primary care: effects on physical capacity and health-related quality of life. Eur J Cardiovasc Nurs 2011;10:150-8. [PMID: 21470913 DOI: 10.1016/j.ejcnurse.2011.03.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
75 Guimarães GV, Carvalho VO, Bocchi EA. Reproducibility of the self-controlled six-minute walking test in heart failure patients. Clinics (Sao Paulo) 2008;63:201-6. [PMID: 18438574 DOI: 10.1590/s1807-59322008000200008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
76 Morales-blanhir JE, Palafox Vidal CD, Rosas Romero MDJ, García Castro MM, Londoño Villegas A, Zamboni M. Teste de caminhada de seis minutos: uma ferramenta valiosa na avaliação do comprometimento pulmonar. J bras pneumol 2011;37:110-7. [DOI: 10.1590/s1806-37132011000100016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
77 Lee KS, Moser DK. Heart failure symptom measures: critical review. Eur J Cardiovasc Nurs 2013;12:418-28. [PMID: 23303769 DOI: 10.1177/1474515112473235] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]